健康元:健康元药业集团股份有限公司2024年可持续发展报告(英文版)

FortheHealthFortheFuture
CONTENTS
01 The Report at a Glance...... 4

02 Chairman’s Statement...... 6

03 About Joincare...... 8 04 Sustainability Management..... 16
3.1 Group Overview...... 9 4.1 Sustainability Governance...... 17
3.2 Organisational Structure...... 12 4.2 Sustainability Strategy...... 18
3.3 Corporate Culture...... 13 4.3 Impact, Risk and Opportunity

3.4 Key Performance ...... 13 Management...... 23
3.5 Honours...... 14 4.4 Support for United Nations

Sustainable Development Goals...... 26
05 Responsible Governance...... 30 06 Safeguarding Product Quality.40
5.1 Compliance Governance...... 31 6.1 Quality Management System...... 41
5.2 Carrying Forward the Party-Masses 6.2 Quality Risk Control...... 48
Spirit...... 34 6.3 Quality Training for Employees...... 52
5.3 Integrity and Business Ethics...... 35 6.4 Intellectual Property Rights

5.4 Information Security...... 39 Protection...... 54
6.5 Protection of Customer Rights and

Interests...... 56
6.6 Supply Chain Management...... 60

07 Access to Healthcare...... 67 08 Talent Management...... 89
7.1 Focusing on R&D and Innovation.. 68 8.1 Protection of Rights and Interests of
7.2 PayingAttention to Rare Diseases Employees...... 90
Treatment...... 75 8.2 Improving Talent Management...... 94
7.3 Improving ProductAvailability...... 76 8.3 Occupational Health and Safety.... 106
7.4 Improving ProductAffordability..... 79

7.5 Improving Healthcare ...... 82
Operating with Green

09 Sustainability......113 10 Public Welfare and Charity... 133
9.1EnvironmentalManagementSystem..114 10.1 Promoting Industry Development..134
9.2Addressing Climate Change......118 10.2 Promoting Health-based Welfare

and Charity...... 135
9.3 Energy Management...... 124

10.3 Engaging in Public Welfare...... 140
9.4 Emission Management...... 126
9.5 Resource Utilisation Management.130

9.6 Biodiversity Conservation...... 132

11 Appendix...... 142
11.1 Index of the Guidelines No. 14 of
Shanghai Stock Exchange for Self-Regu-
lation of Listed Companies—Sustainabili-

ty Report (Trial)...... 142
11.2 Data List of Key Performance

Indicators...... 143

2024 Sustainability Report 01 The Report at a Glance
01 The Report at a Glance
Overview
Since 2018, Joincare Pharmaceutical Group Industry Co., Ltd. (Stock Code: 600380) has consecutively issued corporate social
responsibility (CSR) reports for seven years. Starting from this year, we have renamed the report as the "Sustainability Report",
aiming to present comprehensively to the stakeholders the Group's commitments, measures and performance in the aspects
of fulfilling social responsibility, managing environmental sustainability and corporate governance from a more professional
perspective. The report covers the period from 1 January 2024 to 31 December 2024. In view of the continuity and comparability
of certain data, some contents of this report may be extended or traced back to other periods where applicable.
Scope of the Report
The report covers Joincare and its wholly-owned subsidiaries and holding subsidiaries, which is consistent with the scope of the
consolidated financial statements in the annual report.
Preparation Basis
This report is prepared mainly in accordance with the Guidelines No. 14 of Shanghai Stock Exchange for Self-Regulation of
Listed Companies—Sustainability Report (Trial) and the Corporate Sustainability Disclosure Standards—Basic Standards (For
Trial Implementation), and meanwhile refers to the Environmental, Social and Governance Reporting Code published by the
Hong Kong Stock Exchange. To ensure the completeness, materiality, authenticity and balance of the content, the preparation of
this report has gone through a systematic set of procedures, including identifying key stakeholders, identifying and prioritising
material issues, determining the scope of this report, collecting relevant materials and data, reviewing the data and preparing the
report based on the information gathered.
Definitions
For the sake of compend